secwatch / observer

Executive movement radar

Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.

Launch 75371 grounded facts newest July 14, 2026, 10:49 AM ET RSS · JSON

Showing 4551–4600 of 34692

Departed

Sanjay Prasad

Director
SFCX · SUPA Consolidated Inc.
Effective
2025-02-06
Filed
February 7, 2025, 6:59 PM ET
On February 6, 2025, Mr. Joseph Grimes, Mr. Sanjay Prasad and Mr. Steven Ritacco, each resigned from the Board of Directors of TRIBAL RIDES INTERNATIONAL CORP.
Departed

Joseph Grimes

Director
SFCX · SUPA Consolidated Inc.
Effective
2025-02-06
Filed
February 7, 2025, 6:59 PM ET
On February 6, 2025, Mr. Joseph Grimes, Mr. Sanjay Prasad and Mr. Steven Ritacco, each resigned from the Board of Directors of TRIBAL RIDES INTERNATIONAL CORP.
Departed

Steven Ritacco

Director
SFCX · SUPA Consolidated Inc.
Effective
2025-02-06
Filed
February 7, 2025, 6:59 PM ET
On February 6, 2025, Mr. Joseph Grimes, Mr. Sanjay Prasad and Mr. Steven Ritacco, each resigned from the Board of Directors of TRIBAL RIDES INTERNATIONAL CORP.
Departed

Liam K. Griffin

director
SWKS · SKYWORKS SOLUTIONS, INC.
Effective
2025-02-04
Filed
February 6, 2025, 6:59 PM ET
the Board accepted Mr. Griffin’s offer to resign as a member of the Board
Appointed

Philip G. Brace

director
SWKS · SKYWORKS SOLUTIONS, INC.
Effective
2025-02-17
Filed
February 6, 2025, 6:59 PM ET
appointed Philip G. Brace as the Chief Executive Officer and President of the Company and as a director, effective February 17, 2025
Appointed

Michael J. Barber

Director
XRAY · DENTSPLY SIRONA Inc.
Effective
2025-02-05
Filed
February 6, 2025, 6:59 PM ET
the Board appointed Messrs. Michael J. Barber and Daniel T. Scavilla to the Board, effective immediately.
Appointed

Daniel T. Scavilla

Director
XRAY · DENTSPLY SIRONA Inc.
Effective
2025-02-05
Filed
February 6, 2025, 6:59 PM ET
the Board appointed Messrs. Michael J. Barber and Daniel T. Scavilla to the Board, effective immediately.
Departed

Dorothea Wenzel

Director
XRAY · DENTSPLY SIRONA Inc.
Effective
2025-02-05
Filed
February 6, 2025, 6:59 PM ET
Dr. Dorothea Wenzel notified the Board of her resignation as a member of the Board, effective immediately.
Appointed

Alexander Moczarski

Director
ACGL · ARCH CAPITAL GROUP LTD.
Effective
2025-02-04
Filed
February 6, 2025, 6:59 PM ET
On February 4, 2025, Arch Capital Group Ltd.’s (“ACGL”) Board of Directors (“Board”) unanimously approved the appointment of Alexander Moczarski to serve as a Class III director of the Board, effective February 4, 2025.
Departed

Gail Schulze

Director
CERS · CERUS CORP
Filed
February 6, 2025, 6:59 PM ET
On February 2, 2025, Gail Schulze, a member of the class of directors whose terms of office expire at the 2025 annual meeting of stockholders (the “2025 Annual Meeting”) of Cerus Corporation (the “Company”), informed the Company that she would not stand for re-election at the 2025 Annual Meeting.
Departed

Lara H. Balazs

Director
FTDR · Frontdoor, Inc.
Filed
February 6, 2025, 6:59 PM ET
On February 5, 2025, Lara H. Balazs notified the Board of Directors of Frontdoor, Inc. (the “Company”) that she does not intend to stand for re-election as a director of the Company when her term expires at the Company’s 2025 annual meeting of stockholders.
Appointed

Sue Gove

Director
LKQ · LKQ CORP
Effective
2025-02-05
Filed
February 6, 2025, 6:59 PM ET
On February 5, 2025, Ms. Gove and Mr. Powell were appointed to the Board, each with a term expiring at the 2025 annual meeting of shareholders.
Appointed

Michael Powell

Director
LKQ · LKQ CORP
Effective
2025-02-05
Filed
February 6, 2025, 6:59 PM ET
On February 5, 2025, Ms. Gove and Mr. Powell were appointed to the Board, each with a term expiring at the 2025 annual meeting of shareholders.
Departed

Herbert Simon

Chairman Emeritus
SPG · SIMON PROPERTY GROUP INC.
Effective
2025-02-04
Filed
February 6, 2025, 6:59 PM ET
On February 4, 2025, Herbert Simon, age 90, a member and Chaiman Emeritus of the Board of Directors (the “Board”) of Simon Property Group, Inc. (the “Company”) notified the Company that he is retiring from the Board, including his position as Chairman Emeritus, effective as of such date.
Departed

Timothy Ramdeen

director
GRDX · GridAI Technologies Corp.
Effective
2025-02-03
Filed
February 6, 2025, 6:59 PM ET
On February 3, 2025 (i) each of Timothy Ramdeen, Alastair Riddell and James Sapirstein resigned as directors of the Company
Appointed

Alson Niu

director
GRDX · GridAI Technologies Corp.
Effective
2025-02-03
Filed
February 6, 2025, 6:59 PM ET
the Company’s Board of Directors appointed Manpreet Uppal, Alson Niu and Richard Joel Paolone as directors of the Company
Appointed

Manpreet Uppal

director
GRDX · GridAI Technologies Corp.
Effective
2025-02-03
Filed
February 6, 2025, 6:59 PM ET
the Company’s Board of Directors appointed Manpreet Uppal, Alson Niu and Richard Joel Paolone as directors of the Company
Appointed

Richard Joel Paolone

director
GRDX · GridAI Technologies Corp.
Effective
2025-02-03
Filed
February 6, 2025, 6:59 PM ET
the Company’s Board of Directors appointed Manpreet Uppal, Alson Niu and Richard Joel Paolone as directors of the Company
Departed

James Sapirstein

director
GRDX · GridAI Technologies Corp.
Effective
2025-02-03
Filed
February 6, 2025, 6:59 PM ET
On February 3, 2025 (i) each of Timothy Ramdeen, Alastair Riddell and James Sapirstein resigned as directors of the Company
Departed

Alastair Riddell

director
GRDX · GridAI Technologies Corp.
Effective
2025-02-03
Filed
February 6, 2025, 6:59 PM ET
On February 3, 2025 (i) each of Timothy Ramdeen, Alastair Riddell and James Sapirstein resigned as directors of the Company
Departed

Keijiero Varela

Director
TCRG · Cannaisseur Group Inc.
Effective
2024-03-12
Filed
February 6, 2025, 6:59 PM ET
On February 27, 2024, Mr. Keijiero Varela tendered his resignation, effective March 12, 2024 (the “Effective Date”), as Director of The Cannaisseur Group, Inc. (the “Company”), to pursue other business opportunities.
Departed

Harold 'Butch' Woolfolk

Director
TCRG · Cannaisseur Group Inc.
Effective
2024-12-13
Filed
February 6, 2025, 6:59 PM ET
On December 4, 2024, Mr. Harold "Butch" Woolfolk tendered his resignation, effective December 13, 2024 (the "Effective Date"), as Director of The Cannaisseur Group, Inc. (the "Company"), to pursue other business opportunities.
Appointed

Hans-Juergen Woerle, M.D.

Class III director
MCRB · Seres Therapeutics, Inc.
Effective
2025-02-04
Filed
February 6, 2025, 6:59 PM ET
appointed Hans-Juergen Woerle, M.D., as a Class III director of the Company, effective immediately.
Departed

Karl Peterson

Director
SABR · Sabre Corp
Effective
2025-04-23
Filed
February 6, 2025, 6:59 PM ET
On February 6, 2025, Sabre Corporation (“Sabre”) announced that Karl Peterson will be retiring from the Board, as well as from all Board committees on which he sits, effective immediately prior to Sabre’s 2025 Annual Meeting of Stockholders, which is scheduled to be held on April 23, 2025.
Departed

Angus C. Russell

director
Revance Therapeutics, Inc.
Effective
2025-02-06
Successor
Jeffery A Bedard
Filed
February 6, 2025, 6:59 PM ET
at the Effective Time, each of the directors of the Company (Angus C. Russell, Chris Nolet, Jill Beraud, Vlad Coric, Mark J. Foley, Julian S. Gangolli, Carey O’Connor Kolaja and Olivia C. Ware) resigned as directors of the Company.
Departed

Chris Nolet

director
Revance Therapeutics, Inc.
Effective
2025-02-06
Successor
Jeffery A Bedard
Filed
February 6, 2025, 6:59 PM ET
at the Effective Time, each of the directors of the Company (Angus C. Russell, Chris Nolet, Jill Beraud, Vlad Coric, Mark J. Foley, Julian S. Gangolli, Carey O’Connor Kolaja and Olivia C. Ware) resigned as directors of the Company.
Departed

Vlad Coric

director
Revance Therapeutics, Inc.
Effective
2025-02-06
Successor
Jeffery A Bedard
Filed
February 6, 2025, 6:59 PM ET
at the Effective Time, each of the directors of the Company (Angus C. Russell, Chris Nolet, Jill Beraud, Vlad Coric, Mark J. Foley, Julian S. Gangolli, Carey O’Connor Kolaja and Olivia C. Ware) resigned as directors of the Company.
Departed

Julian S. Gangolli

director
Revance Therapeutics, Inc.
Effective
2025-02-06
Successor
Jeffery A Bedard
Filed
February 6, 2025, 6:59 PM ET
at the Effective Time, each of the directors of the Company (Angus C. Russell, Chris Nolet, Jill Beraud, Vlad Coric, Mark J. Foley, Julian S. Gangolli, Carey O’Connor Kolaja and Olivia C. Ware) resigned as directors of the Company.
Departed

Jill Beraud

director
Revance Therapeutics, Inc.
Effective
2025-02-06
Successor
Jeffery A Bedard
Filed
February 6, 2025, 6:59 PM ET
at the Effective Time, each of the directors of the Company (Angus C. Russell, Chris Nolet, Jill Beraud, Vlad Coric, Mark J. Foley, Julian S. Gangolli, Carey O’Connor Kolaja and Olivia C. Ware) resigned as directors of the Company.
Appointed

Jeffery A Bedard

director
Revance Therapeutics, Inc.
Effective
2025-02-06
Filed
February 6, 2025, 6:59 PM ET
Jeffery A Bedard became the sole director of the Company.
Departed

Olivia C. Ware

director
Revance Therapeutics, Inc.
Effective
2025-02-06
Successor
Jeffery A Bedard
Filed
February 6, 2025, 6:59 PM ET
at the Effective Time, each of the directors of the Company (Angus C. Russell, Chris Nolet, Jill Beraud, Vlad Coric, Mark J. Foley, Julian S. Gangolli, Carey O’Connor Kolaja and Olivia C. Ware) resigned as directors of the Company.
Departed

Mark J. Foley

director
Revance Therapeutics, Inc.
Effective
2025-02-06
Successor
Jeffery A Bedard
Filed
February 6, 2025, 6:59 PM ET
at the Effective Time, each of the directors of the Company (Angus C. Russell, Chris Nolet, Jill Beraud, Vlad Coric, Mark J. Foley, Julian S. Gangolli, Carey O’Connor Kolaja and Olivia C. Ware) resigned as directors of the Company.
Departed

Carey O’Connor Kolaja

director
Revance Therapeutics, Inc.
Effective
2025-02-06
Successor
Jeffery A Bedard
Filed
February 6, 2025, 6:59 PM ET
at the Effective Time, each of the directors of the Company (Angus C. Russell, Chris Nolet, Jill Beraud, Vlad Coric, Mark J. Foley, Julian S. Gangolli, Carey O’Connor Kolaja and Olivia C. Ware) resigned as directors of the Company.
Appointed

Anthony Eisen

Class III Director
XYZ · Block, Inc.
Effective
2025-02-06
Filed
February 6, 2025, 6:59 PM ET
On February 6, 2025, the Board of Directors (the “Board”) of Block, Inc. (the “Company”) increased the size of the Board from nine to ten directors and elected Anthony Eisen to the Board as a Class III director, effective February 6, 2025.
Appointed

Peter R. Sachse

Director
SGI · SOMNIGROUP INTERNATIONAL INC.
Effective
2025-02-05
Filed
February 6, 2025, 6:59 PM ET
Pursuant to the terms of the Merger Agreement, the Board of Directors (the "Board") of the Company approved an increase of the size of the Board from 7 to 8 members effective February 5, 2025 and filled the newly created vacancy by appointing Peter R. Sachse, as an independent director, to serve on the Board, effective on the same day.
Appointed

Robert McGuire

independent director
Aerkomm Inc.
Effective
2025-02-03
Filed
February 6, 2025, 6:59 PM ET
the Board appointed Mr. Robert McGuire to become an independent member of the Board effectively immediately
Departed

Colin Lim

independent director
Aerkomm Inc.
Filed
February 6, 2025, 6:59 PM ET
recently created by the resignation of two of the Company’s independent directors, Mr. Colin Lim and Mr. Raymond Choy.
Departed

Raymond Choy

independent director
Aerkomm Inc.
Filed
February 6, 2025, 6:59 PM ET
recently created by the resignation of two of the Company’s independent directors, Mr. Colin Lim and Mr. Raymond Choy.
Departed

Yingda Wu

Member of the Board of Directors
KUBR · Kuber Resources Corp
Effective
2025-01-20
Filed
February 6, 2025, 6:59 PM ET
On January 20, 2025, Yingda Wu, a member of the Board of Directors of Kuber Resources Corp. (the “Company”), tendered his resign from the Company's Board of Directors, effective January 20, 2025.
Appointed

Matthew Pine

Director
TT · Trane Technologies plc
Effective
2025-04-01
Filed
February 6, 2025, 6:59 PM ET
elected Matthew Pine, President and CEO of Xylem Inc., to serve as an independent member of the Board, effective April 1, 2025.
Appointed

Jon Paul Pérez

Director
TGLS · Tecnoglass Inc.
Effective
2025-02-04
Successor
Lorne A. Weil
Filed
February 6, 2025, 6:59 PM ET
On February 4, 2025, the Board of Directors (the “Board”) of Tecnoglass Inc. (the “Company”) appointed Jon Paul “JP” Pérez to fill the vacancy on the Board created by Lorne A. Weil’s resignation previously disclosed on January 6, 2025.
Departed

Zachary Rome

Director
PaxMedica, Inc.
Effective
2025-01-31
Filed
February 6, 2025, 6:59 PM ET
On January 31, 2025, Zachary Rome resigned from the Board for personal reasons, effective immediately.
Appointed

Joseph Manchin III

Director
ATH-PA · Athene Holding Ltd.
Effective
2025-02-03
Filed
February 6, 2025, 6:59 PM ET
On February 3, 2025, former U.S. Senator Joseph Manchin III was appointed to the Board of Directors (“Board”) of Athene Holding Ltd. (the “Company”).
Appointed

Marc Carlson

Class II director
MDRR · Medalist Diversified, Inc.
Effective
2025-01-31
Filed
February 6, 2025, 6:59 PM ET
On January 31, 2025, the Board of Directors (the “Board”) of Medalist Diversified REIT, Inc. (the “Company”) appointed Marc Carlson, as a Class II director of the Company, effective immediately.
Appointed

Charles P. Blankenship, Jr.

Director
FLR · FLUOR CORP
Effective
2025-03-01
Filed
February 6, 2025, 6:59 PM ET
The Board elected Mr. Charles P. Blankenship, Jr., effective March 1, 2025, to fill the new position authorized by the Board.
Appointed

Dietmar Berger

Class II Director
RCUS · Arcus Biosciences, Inc.
Effective
2025-02-06
Filed
February 6, 2025, 6:59 PM ET
On February 6, 2025, the Board appointed Dietmar Berger M.D., Ph.D., as a Class II director to fill the vacancy left by Dr. Parsey's resignation.
Departed

Merdad Parsey

Director
RCUS · Arcus Biosciences, Inc.
Effective
2025-02-06
Successor
Dietmar Berger
Filed
February 6, 2025, 6:59 PM ET
On February 6, 2025, in connection with his departure from Gilead Sciences, Inc. (“Gilead”), Merdad Parsey, M.D., Ph.D., resigned as a member of Arcus Biosciences, Inc.’s (“Arcus”) Board of Directors (the “Board”), effective upon the appointment of Gilead’s new director designee pursuant to the Amended and Restated Investor Rights Agreement dated January 29, 2024 by and between Arcus and Gilead.
Departed

Jaydriane Panis

Director
Virpax Pharmaceuticals, Inc.
Effective
2025-02-03
Successor
Charn Deol
Filed
February 6, 2025, 6:59 PM ET
Jaydriane (Jay) Panis, who resigned from the Board on February 3, 2025.
Appointed

Charn Deol

Director
Virpax Pharmaceuticals, Inc.
Effective
2025-02-05
Filed
February 6, 2025, 6:59 PM ET
appointed Mr. Charn Deol as an independent director of the Company, effective immediately.
Departed

William A. Kozy

Director
COO · COOPER COMPANIES, INC.
Filed
February 5, 2025, 6:59 PM ET
On January 31, 2025, William A. Kozy informed the Board of Directors (the "Board") that he will retire as a director, effective on the date of The Cooper Companies, Inc.'s (the "Company's") next Annual Meeting of Stockholders in April 2025 (the "Annual Meeting").

Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.